including South Africa, until cheaper generics become available in 2027. Up until the end of 2024, Pepfar funded 91% of preventive HIV medication — mainly a daily pill — in poorer countries ...

Research led by Professor Adrie Bekker is paving the way for an important HIV medicine to be made available to neonates in a ...